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Herein is our revised version of the review article CONEUR_2017_101 ‘Microglia: origins, 
homeostasis, and roles in myelin repair’. We appreciate the reviewer’s comment that the review is 
well written, concise, and timely, and have addressed all the suggestions which have been 
highlighted in yellow in the text, and described below:
At least some mention could be made of the potential "dark side" of microglia/MDMs in 
demyelinating disease, even if only to put the current focus on their beneficial roles into a 
historical perspective (e.g., contribution to oxidative stress, inflammatory cytokine production...)
We have added the following to the introduction:  ‘As such, microglia are early responders to CNS 
damage or abnormality and are thus placed to quickly coordinate subsequent responses. These can 
be damaging, for instance in contributing to neurodegeneration3, dysregulated synaptic pruning4, 
and associated with dementia5, reviewed in detail elsewhere6.’ We chose not to elaborate on the 
damaging aspects of microglia reactions further due to existing review articles on this topic, and our 
focus on the regenerative properties. The damaging effects of MDMs are outlined in main text, as 
described in answer to the reviewer’s second comment, below. 
The discussion of the differing transcriptional profiles of resident microglia and MDMs during 
demyelination is interesting but would be complemented by greater focus on the few studies that 
have shown functional differences between the two populations. The description of the recent 
TNFR2 ablation study by Gao et al. (2017) is a good start but could be complemented by Yamasaki 
et al. (2014)’s findings that MDMs appear to show greater association with nodes of Ranvier in 
EAE, actively removing myelin segments. Ajami et al., 2011 (Nature Neuroscience 14, 1142–1149) 
could also be used as evidence for functionally distinct roles between the two.
In addition to the description of distinct microglia and MDM functions in EAE from Yamasaki and 
Lewis papers, we have now added the following to the main text: ‘Other studies have demonstrated 
the requirement for MDM in initiating EAE disease and progression51 via CCR2 signalling52,53; 
accordingly, Yamasaki et al. showed that MDMs in close association with axoglial units have myelin 
inclusions49, suggesting that these cells may directly induce demyelination’, referencing the above 
studies and some additional ones we found were relevant.
Figure: Consider including OPCs/OLs in the diagram and indicate where some of the microglia 
functions are thought to act on the lineage.
We have updated the figure to include the oligodendroglial lineage cell responses.
“Microglia are the resident tissue macrophages in the central nervous system (CNS), comprising up 
to 12-16 % of total neural cells in mouse and human". These figures seem to be the upper 
estimates, with figures for most CNS regions being somewhat below these percentages. The 
sentence could be revised to reflect more typical estimates
We have updated the sentence to read: ‘Microglia are the resident tissue macrophages in the 
central nervous system (CNS), comprising 5-12 % of total neural cells in mouse brain and 0.5-16% in 
human brain1,2’
Best regards
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Abstract
Microglia are the resident macrophages of the central nervous system (CNS), implicated in 
developmental processes, homeostasis, and responses to injury. Derived from the yolk sac 
during development, microglia self-renew, self-regulate their numbers during homeostatic 
conditions, and show a robust proliferative capacity even in adulthood. Together with 
monocyte-derived macrophages (MDM), microglia coordinate the regeneration of CNS 
myelin around axons, termed remyelination. Gene expression analyses and experimental 
modelling have identified pro-remyelination roles for microglia/ MDM in clearance of myelin 
debris, secretion of growth factors, and remodelling of the extracellular matrix. Further 
investigations into the molecular mechanisms controlling these regenerative functions will 
reveal novel therapeutic strategies to enhance remyelination, by harnessing the beneficial 
effects of the innate immune response to injury. 
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Introduction
Microglia are the resident tissue macrophages in the central nervous system (CNS), 
comprising 5-12 % of total neural cells in mouse brain and 0.5-16% in human brain1,2. As 
members of the innate immune system, a major function of microglia is to survey the 
microenvironment for signs of injury, such as damage-associated molecular patterns 
(DAMPs) released from dying or stressed cells. As such, microglia are early responders to 
CNS damage or abnormality and are thus placed to quickly coordinate subsequent 
responses. These can be damaging, for instance in contributing to neurodegeneration3, 
dysregulated synaptic pruning4, and associated with dementia5, reviewed in detail 
elsewhere6. However, although less studied, microglial post-injury responses can also be 
regenerative; indeed, studies over the past 16 years have revealed the supportive role of 
macrophages (i.e. microglia and monocyte-derived macrophages (MDMs)) in the 
regeneration of myelin, termed remyelination7-15. 
Remyelination reinstates and preserves axonal function and health16-20. This involves 
recruitment and proliferation of oligodendrocyte progenitor cells (OPCs), their 
differentiation into mature oligodendrocytes, and ensheathment of axons with new myelin. 
The failure of remyelination in various neurological contexts, such as with ageing and in 
progressive multiple sclerosis (MS), is considered to contribute to the axonal loss which 
correlates to decline in motor, sensory, and cognitive functions. Failed remyelination with 
ageing has been associated with dysregulated macrophage responses in experimental 
models10,11,21, highlighting a key pro-regenerative therapeutic target. Although clinical trials 
aimed at enhancing remyelination by directly stimulating oligodendrocyte lineage cells are 
currently ongoing for the first time, whether these drugs will be successful, and whether 
they will work efficiently in all patients, remains to be seen. Given the plethora of evidence 
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implicating macrophages in remyelination in both rodent and human pathological studies, 
further investigations into microglia biology will reveal novel therapeutic strategies based 
on manipulating the innate immune response. Here, we summarize current knowledge on 
microglia development, homeostasis, and gene expression/ functions during remyelination.
Origins, maintenance, & repopulation of microglia during homeostasis
Microglia regulate developmental processes, including but not limited to oligodendrocyte 
differentiation22, neural precursor migration23, and synaptic pruning24.  Accordingly, 
microglia arise early on in development, populating the murine neuroepithelium by 
embryonic day 9.5 (E9.5)25, and subsequently being closed off from the periphery by the 
formation of the blood brain barrier by E13.5. Between E10.5 and birth, microglia rapidly 
proliferate to colonise the CNS, maturing into ramified microglia26. This early CNS 
colonisation of microglia is conserved across vertebrates27. Indeed, in humans, Iba-1+ CD68+ 
CD45+ MHCII+ amoeboid microglia penetrate the cerebral cortex by gestational week (gw) 
4.528,29 and migrate to the immature white matter via the ventricular lumen and 
leptomeninges28. A second wave of infiltration of microglia at 12-13 gw then seeds the 
embryonic brain via the vasculature29. By 22 gw, microglia take on a ramified morphology, 
becoming fully mature by 35 gw. 
Microglia originate from erythromyeloid progenitors (EMPs) in the yolk sac25, elegantly 
shown using fate mapping where progenitor cells expressing runt-related transcription 
factor 1 (Runx1) express yellow fluorescent protein (YFP) after tamoxifen-induced Cre 
recombination. Specific labelling of yolk sac EMPs in embryos, achieved by injection of 4-
hydroxytamoxifen (4-OHT) into pregnant females prior to foetal liver haematopoiesis (at 
E7.5), allowed tracing of YFP+ cells to the rudimental brain25. This migratory process is 
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circulation-dependant, as Ncx-1-/- mice devoid of a functioning blood circulation lack 
microglia30 despite undergoing normal haematopoiesis25. Although yolk sac EMP-derived 
primitive macrophages can colonise the whole embryo by E9.5, these cells are committed to 
a microglia fate by downregulation of Timd4 and Cd206 and upregulation of Sall1 and 
Sall331. In addition, interferon regulatory factor 8 (Irf8), working in a heterodimeric 
partnership with Pu1, is a critical survival factor expressed during early microgliogenesis, 
essential for microglia development and specification26. Furthermore, RNAseq analysis 
revealed that the precise coordination of gene expression directs differentiation of early 
progenitors (expressing Mcm5, Dab2, Lyz2 and Pf4) into post-natal microglia (upregulating 
Csf1R and Cxcr2) and finally into mature microglia (expressing Cd14 and Mafb)32.  Yolk sac-
derived microglia can persist until adulthood25,33,34, yet it cannot be dismissed that a small 
proportion of microglia may be replaced by haematopoietic stem cells (HSCs) since in 
zebrafish, adult microglia originate from the ventral wall of the dorsal aorta, a source of 
definitive haematopoiesis33.  
After birth, microglial numbers initially increase in the first two weeks of life, followed by a 
decrease to a steady homeostatic level via apoptosis and reduced proliferation35,36. Under 
homeostatic conditions, yolk-sac derived microglia were historically considered to be long-
lived cells with low turnover. However, recent evidence has shown that the microglia 
population in the mouse brain is dynamically regulated at the individual cell level via 
coupling of apoptosis and proliferation, with a minimum of 1.38% of microglia estimated to 
be proliferating (as shown by BrdU incorporation) at any given time and 1.23% of microglia 
dying every 24 hours37. Altogether, it is therefore estimated that a whole microglial 
population in the murine CNS can turn over in 96 days.  In human brain, slightly higher rates 
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of proliferation were observed (Ki67+ Iba-1+ cells)37, but rates of death are unknown. 
Dynamic regulation of the microglia population in the adult mouse brain has also been 
observed by repopulation from CNS-endogenous cells following global depletion of 
microglia38-41. These studies involved adult mice, thereby revealing that repopulation of 
microglia occurs in a mode distinct from the original seeding in development. There are 
currently 2 proposed models of microglia repopulation. The first study, using a Cx3cr1-
CreERT2;iDTR mouse model, ablated a minimum of 80% of microglia in the cortex, 
cerebellum, and spinal cord by 3 days post-diphtheria toxin40. A subsequent rapid 
repopulation was observed at 7 days post-diphtheria toxin, mediated by self-renewing 
proliferating microglia (expressing Nestin), with numbers returning back to control levels 1 
week later40. The second model, where >90% of microglia were depleted using a CSF1R 
inhibitor, observed repopulation from a CX3CR1-negative CNS-resident cell39. BrdU labelling 
showed that 70% of labelled cells were positive for Nestin but negative for microglia 
markers such as Iba-1. When repopulation was complete, almost all BrdU labelled cells were 
positive for microglial markers, leading to the conclusion that the Nestin+ cells 
differentiated into microglia39.  These repopulating cells heterogeneously expressed a range 
of markers for hematopoietic stem cells or neural stem cells including Nestin, CD34, and c-
kit, as well as lectin-IB4, CD45, and Ki6739. Further investigations showed that the 
repopulated microglia have similar inflammatory gene expression and functional responses 
to lipopolysaccharide compared to pre-depletion microglia39, however the identity and 
origin of these cells remains unclear and is hotly debated. Definitive lineage tracing and 
RNA-sequencing of Nestin+ cells should ultimately uncover their identity and role in the 
CNS.  Differences in between these two studies may reflect different levels of depletion 
(>99%39 compared to 80%40), and only the DTR-driven depletion leading to a robust pro- 
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inflammatory response and astrogliosis40. Although there is uncertainty as to the role of 
Nestin in microglia repopulation, be it re-expression by residual microglia40 or cells 
potentially capable of differentiating into microglia39, it is clear that cells expressing Nestin 
are nonetheless integral to the rapid repopulation of microglia following depletion. 
Determining whether the dynamic regulation of microglial turnover/ repopulation is 
dysregulated in the context of failed remyelination may be critical in understanding how to 
therapeutically target microglia. 
Transcriptional profiles of microglia and monocyte-derived macrophages during central 
nervous system remyelination
The importance of inflammation and microglia/ MDM in remyelination was initially 
suggested by transcriptomic studies of whole remyelinating lesions. For example, a 
microarray gene expression analysis of whole mouse brain tissue following cuprizone toxin-
induced demyelination revealed regulation of genes associated with inflammation and/or 
the recruitment/stimulation of macrophages. For instance, lysozyme M (LyzM) and 
leukocyte common antigen/CD45 (Ptprc), and genes associated with recruitment/ activation 
of macrophages (Ccl2 (MCP-1), Ccl9 (MIPγ), Ccr5, Mmp12), were upregulated at the time of 
concomitant demyelination and initiation of remyelination (6 weeks after initiation of 
cuprizone treatment) and subsequently downregulated during the later stages of 
remyelination (6 weeks recovery on normal diet)42. Downregulation of these genes during 
late remyelination coincided with the upregulation of myelin-associated genes (such as 
proteolipid protein 1 (Plp), myelin associated glycoprotein (Mag), myelin oligodendrocyte 
glycoprotein (Mog)), as well as synectin (Gipc1), BCL tumour suppressor 7C (Bcl7c), 
lysophosphatidic acid receptor 1 (Lpar1; important for Schwann cell myelination43), kinesin 
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family member 5A (Kif5a; required for transport of neurofilament), and NK6 transcription 
factor related (Gtx; expressed during myelination and remyelination44). To further identify 
genes involved in remyelination, Arnett, et al. 45 analysed whole brains isolated from Tnfa-/- 
mice, which do not remyelinate efficiently after cuprizone-induced demyelination. In 
comparison to wildtype mice, microarray analysis identified differential expression of genes 
during remyelination (6 weeks recovery on normal diet after 6 weeks of cuprizone diet) 
associated with the immune response (downregulation of Mhc-II, Ccr6, Cd19, Cd105; 
upregulation of Ifn), as well as the cell cycle (upregulation of Cyclin-e, Polg, Cdk5r2), 
development (downregulation of Crygd, Crybb2, Igf1/2; upregulation of Fzd, Sema5b) and 
regulation of transcription (upregulation of Myt1)45. 
Importantly, these studies support that the immune response is a critical component of 
remyelination; however, these results do not reflect transcriptional profiles of individual cell 
populations. Indeed, Srinivasan, et al. 46 showed that the expression profiles of cells 
extracted from tissues affected by neurodegenerative disease are influenced by cell 
composition, and whole tissue RNA analysis may obscure significant gene changes in 
microglia and, thus, could be misleading. Similarly, some studies have combined microglia 
and MDM together for analysis, as a result of the challenges of distinguishing and isolating 
microglia from MDM47. To overcome this, Lewis, et al. 48 isolated microglia from MDM by 
fluorescence-activated cell sorting (FACS) using differential expression of the surface marker 
CD44, and investigated the transcriptomes of these cell populations in the pathogenesis of 
experimental autoimmune encephalomyelitis (EAE). Microglia and MDM were isolated from 
naive mouse brains when clinical symptoms were absent (at 7 days post immunisation; 
disease score of 0) and when partial hind-limb paralysis was observed (at 14 days post 
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immunisation; disease score of 3), and transcriptomes were determined using RNA 
sequencing. Principal component analysis revealed that the two cell populations remained 
distinct at the transcriptome level during the course of EAE. The distinct microglia and MDM 
expression profiles during EAE were confirmed in a separate study49, which identified that 
MDM were more likely than microglia to express genes related to effector functions, 
including secreted factors and surface molecules. Furthermore, it was recently shown that 
differential expression of genes by microglia and MDM can lead to differing functions in EAE 
pathogenesis. For instance, microglial expression of tumour necrosis factor receptor 2 
(Tnfr2) is protective against EAE, whilst MDM expression of Tnfr2 drives immune cell 
activation and initiation of EAE50. Other studies demonstrated the requirement for MDM in 
initiating EAE disease and progression51 via CCR2 signalling52,53; accordingly, Yamasaki et al. 
showed that MDMs in close association with axoglial units have myelin inclusions49, 
suggesting that these cells may directly induce demyelination. These studies highlight the 
differential functions of microglia and macrophages during myelin injury, and point to the 
requirement to analyse these populations separately to accurately assess their roles during 
remyelination.
Using this approach, Olah et al. performed microarray analysis of microglia isolated from 
cuprizone-treated mice and identified 6200 genes expressed during homeostasis, 
demyelination and remyelination13. The major patterns observed were i) downregulation of 
metabolic processes and acute inflammatory responses during demyelination and 
remyelination; ii) upregulation of cell cycle during demyelination only; and iii) upregulation 
of immune response, phagocytosis and antigen processing/presentation during 
demyelination and remyelination13. However, the microglial transcriptome was largely 
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similar between demyelination/ early remyelination (5 weeks cuprizone treatment) and late 
remyelination (5 weeks cuprizone treatment then 2 weeks recovery). At both these time 
points, microglia upregulated expression of toll-like receptor 4 (Tlr4), lysozyme 1 and 2 
(Lyz1, Lyz2), tumour necrosis factor (Tnf), interleukin 1β (Il1b), interleukin receptor 4α 
(Il4ra), genes associated with MHC-II (Cd74, H2Aa), whilst common microglial markers such 
as Iba1 (Aif1), F4/80 (Emr1), and Pu.1 (Spi1) were stably expressed. The authors proposed 
numerous microglial effector functions during demyelination and remyelination, including 
phagocytosis of debris/ apoptotic cells, salvage of myelin constituents, recruitment of OPCs 
and trophic support, and tissue remodelling. Overall, this study highlighted that the 
overarching role of microglia is to maintain tissue homeostasis and to provide an 
environment supportive of regeneration, which was even evident during demyelination. 
A significant function associated with microglia is the clearance of myelin debris, which is 
required for remyelination to occur. Impaired removal of myelin debris is one factor 
contributing to poor remyelination following cuprizone treatment of Trem2-/- mice54. This is 
underpinned by impaired upregulation of genes associated with phagocytosis of myelin 
debris (Axl) and molecules central to lipid transport and metabolism (apolipoprotein-E 
(Apoe), apolipoprotein C1 (Apoc1), lipoprotein lipase (Lpl), cholesterol 25-hydroxylase 
(Ch25h)) during demyelination and remyelination. Furthermore, microglia provide trophic 
support to newly recruited OPCs, and a growth factor critical for OPC differentiation (insulin-
like growth factor 1; Igf1) was found to be downregulated in Trem2-/- mice after cuprizone-
induced demyelination. Together, these results suggest that a central role of microglia in 
responding to demyelination is to carry out myelin clearance and promote OPC maturation 
for remyelination to occur efficiently. These studies have elucidated microglia gene 
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expression profiles during demyelination and remyelination, however subsequent unbiased 
investigations into expression profiles of microglia versus MDM during remyelination may 
reveal cell-specific functions during regeneration. 
Functional contributions of microglia and monocyte-derived macrophages to central 
nervous system remyelination
Activated macrophages are a component of remyelinating lesions in both experimental 
models and human disease (e.g. multiple sclerosis, spinal cord injury, Alzheimer’s disease)55. 
For instance, the density of macrophages (HLA-DR+) at the border of MS lesions coincides 
with areas of robust remyelination56. In contrast to experimental models with concurrent 
demyelination and remyelination (such as EAE and the cuprizone model), focal toxin-
induced lesion models with temporally distinct damage and regeneration are the most 
appropriate to specifically associate cellular responses/ gene expression profiles/ molecules 
with the regenerative response to damage. Indeed, a recent study identified that 
remyelination is limited in EAE and occurs only at very late stages20. Conversely, focal 
models show robust remyelination (in young animals) following injection of demyelinating 
agents (such as lysolecithin, ethidium bromide, or lysophosphatidylserine (LPS)) into white 
matter tracts such as the spinal cord, corpus callosum, or caudal cerebellar peduncles. These 
models have been imperative in linking the beneficial effects of the immune response to the 
regulation of OPC responses during remyelination7-11,57. More specifically, this allowed for 
the discovery that macrophages are required for efficient remyelination, given that blocking 
the macrophage response soon after demyelination, either via depletion using clodronate-
liposomes7,10 or by administration of minocycline58, inhibits remyelination. Furthermore, 
inducing macrophage activation is sufficient to enhance myelination or remyelination, for 
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example via stimulation with the Toll-like receptor (TLR)-4 agonist LPS59, TLR-2 agonist 
zymosan60, or a combination of the anti-fungal agent amphotericin B with macrophage 
colony stimulating factor (M-CSF)14. 
Our recent work has identified that efficient remyelination requires the dynamic regulation 
of functional macrophage phenotypes10. More specifically, soon after demyelination 
macrophages adopt expression of inducible nitric oxide synthase (iNOS), CD16/32, and 
tumor necrosis alpha (TNF-α), and support the proliferation of OPCs, yet these pro-
inflammatory macrophages are not required for remyelination to proceed10. Importantly, 
the rate limiting step in remyelination efficiency is the transition to a pro-regenerative 
macrophage phenotype expressing arginase-1, mannose receptor (CD206), and insulin-like 
growth factor-1 (IGF-1) which drives oligodendrocyte differentiation to initiate 
remyelination10. Lineage tracing identified that both microglia and MDM contributed to 
both phenotypes10. Additionally, using Ccr2 knockout mice in which monocytes cannot 
extravasate from bone marrow and are thus excluded from lesions, we observed that 
microglia could undergo this transition in activation even in the absence of MDM10. 
Although the molecular mechanisms underpinning this critical transition in macrophage 
activation are unknown, microglia and MDM gene expression/ activation can be 
manipulated by electrical nerve stimulation61, antipsychotic drug/ calcium suppression62, 
inhibition of Rho Kinase63, modulation of signalling through NFκB (reviewed by Lloyd and 
Miron64), and histone deacetylase (HDAC) inhibition65. 
The aforementioned phagocytosis of myelin debris by macrophages is required for 
remyelination to proceed, as this debris is otherwise inhibitory for the recruitment/ 
differentiation of oligodendrocyte lineage cells9 and potentially for new myelin sheath 
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extension66. Indeed, in MS lesions, the density of oligodendrocyte precursor cells (O4+) is 
proportional to the density of macrophages which have phagocytosed debris67. Microglia 
and MDM may have differential phagocytic potential for engulfment of myelin debris 
depending on the context, being greater in vitro in human primary microglia versus 
MDM68,69 yet relatively repressed in microglia at onset of EAE49. Nonetheless, several 
receptors have been implicated in regulating the phagocytosis of myelin debris: MerTK68, 
TLR466, CX3CR115, TREM254, and RXRα21. For instance, myelin debris clearance is impaired 
following spinal cord injury in TLR4 knockout mice70 and accelerated following TLR4 
stimulation after peripheral nerve injury66. Additionally, stimulation of MS patient-derived 
monocytes with the RXRα agonist bexarotene enhances their phagocytic capacity21. Healy et 
al. found that TGF-β treatment of primary human brain-derived microglia, which renders in 
vitro microglia more like in vivo microglia71, increased myelin ingestion via upregulation of 
MerTK, whilst blocking MerTK decreased phagocytic potential68. Stimulation of human 
microglia and MDMs also influences uptake of myelin in vitro, with highest efficiency seen 
following treatment with M-CSF, interleukin (IL)-13 and IL-469. An additional beneficial role 
of microglia and MDM during remyelination is the release of factors that support 
oligodendrocyte lineage cell responses. These include activin-A, endothelin-2, IGF-1, TNFα, 
IL-1β, platelet-derived growth factor (PDGF)-AA, fibroblast growth factor (FGF)-2, galectin-3, 
osteopontin-M, CXCL12, semaphorin-3F, and iron (reviewed in 72). Thus, it is conceivable 
that these factors synergistically induce coordinated and temporally controlled signalling in 
OPCs which drives their responses during remyelination. Furthermore, macrophages play 
important roles in remodelling the extracellular matrix to support remyelination, for 
instance by degrading chondroitin sulfate proteoglycans73-75. Microglia and MDMs may also 
coordinate a pro-remyelination environment via interaction with other cell types. For 
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instance, a recent study identified that regulatory T cells drive remyelination57, and one may 
speculate that macrophages and regulatory T cells may cooperate to support regeneration. 
Indeed, a recent study found that a secreted phenylalanine oxidase termed interleukin-4-
induced-1 (IL4l1), which is highly enriched in microglia and upregulated during 
remyelination, regulates both macrophage activation during remyelination and reduces T 
cell expansion in EAE, leading to less dystrophic axons76. Using cultures of primary human 
neural cells, another study found that microglia release cytokines which modulate 
astrocytes, which in turn influence OPC responses77. 
Importantly, the failure of remyelination seen with ageing is associated with a reduced 
recruitment of macrophages, reduced activation to a pro-regenerative macrophage 
phenotype10,78, and impaired phagocytic potential11,21,78. Altogether, these findings point 
towards the importance of regulating macrophages following demyelination for efficient 
remyelination to take place, and the need for macrophage-specific targeting in developing 
effective therapeutic strategies for the enhancement of remyelination.
Conclusions
As sensors of damage in the central nervous system, microglia are early responders to 
injury, such as demyelination, and have roles in supporting the regenerative process of 
remyelination. Transcriptomics and functional assays have identified these to include the 
phagocytosis of myelin debris, remodelling of the extracellular matrix, and secretion of 
factors influencing oligodendrocyte lineage cell responses (such as differentiation into 
myelinating oligodendrocytes). Although microglia are likely supported by MDMs in many of 
these functions, whether there are distinct roles of the endogenous and exogenously-
derived macrophages during remyelination, as observed during myelin injury, is unknown. It 
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also remains to be determined whether the dynamic turnover of microglia observed during 
homeostasis is altered during injury and remyelination. Nonetheless, the numerous studies 
implicating macrophages in supporting remyelination highlight that these cells are 
important therapeutic targets for promoting remyelination in various neurological disorders 
characterized by poor myelin integrity.
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Figure legend
In development, erythromyeloid progenitors (EMPs) derived from the yolk sac colonize the 
embryonic brain (at embryonic day 9.5 in mice, and gestational week (gw) 4.5 and 12-13 in 
human). Mouse studies showed these cells will express Runx1, Pu.1, Irf8, Sall1, and Sall3. 
These cells reach full maturation between E10.5 and birth in the mouse, and gw 22-35 in the 
human. In mouse, this involves expression of Csfr1, Cxcr2, Cd14, and Mafb. In adulthood, 
the microglia population turns over regularly by coupled apoptosis (via Bad) and 
proliferation (expression of Mad211, Mdm2, Cdca3, Cdk1, Cdc20, Cdc20b). In the cuprizone 
model of demyelination, injury is associated with microglial expression of LyzM, Ccl2, Ccl19, 
Ccr5, and Mmp12. The regeneration of myelin that ensues (remyelination) is coordinated by 
microglia and monocyte-derived macrophages (MDM) which phagocytose myelin debris, 
remodel tissue, and secrete regenerative factors that altogether affect the recruitment of 
oligodendrocyte progenitor cells (OPCs) via chemoattraction, their proliferation, and 
differentiation into mature myelin-forming oligodendrocytes. Gene expression profiling of 
microglia identified pathways associated with decreased metabolic processing, increased 
immune response, antigen presentation and processing, and expression of Tlr4, Lyz1, Lyz2, 
Tnf, Il1b, Il4ra, Cd74, H2Aa, Axl, Apoe, Apoc1, Lpl, and Ch25h. The remyelination-associated 
gene expression profile in MDM is currently unknown. 
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